We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$20.3B
Cap. Flow %
2.85%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.94%
2 Technology 1.9%
3 Communication Services 1.42%
4 Financials 1.08%
5 Healthcare 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATYR
12201
aTyr Pharma
ATYR
$55.9M
$53K ﹤0.01%
+10,839
New +$46.2K
OIBR.C
12202
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$53K ﹤0.01%
35,775
-17,992
-33% -$27.7K
ATXS
12203
CALL
DELISTED
Astria Therapeutics
ATXS
$52K ﹤0.01%
4,100
-9,917
-71% -$129K
CPSS icon
12204
PUT
Consumer Portfolio Services
CPSS
$200M
$52K ﹤0.01%
11,600
-900
-7% -$3.97K
EVGN icon
12205
CALL
Evogene
EVGN
$8.68M
$52K ﹤0.01%
1,510
-410
-21% -$16.1K
TEF
12206
CALL
DELISTED
Telefonica
TEF
$52K ﹤0.01%
11,792
-7,793
-40% -$33.7K
VAL.WS icon
12207
PUT
Valaris Ltd Warrants
VAL.WS
$821M
$52K ﹤0.01%
+18,200
New +$39.4K
PAVMZ
12208
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$52K ﹤0.01%
+10,875
New +$40.4K
LMNL
12209
CALL
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$52K ﹤0.01%
+1,330
New +$57.9K
LEJU
12210
PUT
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$52K ﹤0.01%
2,610
-2,580
-50% -$54.9K
IVAN.WS
12211
DELISTED
Ivanhoe Capital Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
IVAN.WS
$52K ﹤0.01%
+28,434
New +$40.7K
IMH
12212
CALL
DELISTED
Impac Mortgage Holdings Inc.
IMH
$52K ﹤0.01%
+24,600
New +$50.5K
SCTL
12213
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$51K ﹤0.01%
22,075
+8,003
+57% +$20.3K
APTO
12214
PUT
DELISTED
Aptose Biosciences, Inc.
APTO
$51K ﹤0.01%
34
-32
-48% -$69.7K
VIHAW
12215
DELISTED
VPC Impact Acquisition Holdings Warrant
VIHAW
$51K ﹤0.01%
29,283
ABEV icon
12216
Ambev
ABEV
$45.2B
$50K ﹤0.01%
14,546
-515,947
-97% -$1.68M
CDTX
12217
CALL
DELISTED
Cidara Therapeutics
CDTX
$49K ﹤0.01%
+1,210
New +$51.2K
CMCM
12218
CALL
Cheetah Mobile
CMCM
$94M
$49K ﹤0.01%
4,100
-5,380
-57% -$60.4K
UBX
12219
CALL
DELISTED
Unity Biotechnology
UBX
$49K ﹤0.01%
1,060
-7,790
-88% -$375K
XCUR icon
12220
Exicure
XCUR
$7.79M
$49K ﹤0.01%
+217
New +$56.9K
ETACW
12221
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$49K ﹤0.01%
50,000
ANIX icon
12222
CALL
Anixa Biosciences
ANIX
$125M
$48K ﹤0.01%
+12,300
New +$52.4K
ATXS
12223
PUT
DELISTED
Astria Therapeutics
ATXS
$48K ﹤0.01%
3,767
-29,833
-89% -$387K
EMX
12224
DELISTED
EMX Royalty
EMX
$48K ﹤0.01%
+16,143
New +$52.8K
AIXC
12225
PUT
AIxCrypto Holdings Inc
AIXC
$18.9M
$48K ﹤0.01%
48
-521
-92% -$529K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.